Choice of second biologic in rheumatoid arthritis patients with inadequate response to initial anti-TNF

Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 104(2):19. Epub 2017 Feb 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents
  • Arthritis, Rheumatoid*
  • Biological Products
  • Humans
  • Tumor Necrosis Factor-alpha*

Substances

  • Antirheumatic Agents
  • Biological Products
  • Tumor Necrosis Factor-alpha